Fig. 11
From: Multidimensional applications of prussian blue-based nanoparticles in cancer immunotherapy
(A) Schematic illustration of the synthesis of PMo@CCM and the pathway of enhanced immunotherapy via the combined PTT/CDT treatment and improver presentation of tumor-associated antigens (TAAs) [217]. Copyright 2024, Wiley-VCH GmbH. (B) Schematic illustration of the CS-1@PB[HM] NPs for cancer comprehensive therapy by inducing pyroptosis [218]. Copyright 2023, Elsevier Ltd. (C) Schematic illustration showing the integration of NIR AIEgen with mesoporous PB nanocatalyzer to boost the theranostic performance for NIR-II fluorescence and PA imaging-guided robust cancer immunotherapy [219]. Copyright 2024 Wiley-VCH GmbH. (D) Schematic diagram of the homologous targeted tumor cocktail therapy based on M@P-PDR “Nano-targeted cells” [228]. Copyright 2021, BioMed Central